Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Evonik? Find Budesonide to address your drug delivery challenges on PharmaCompass.

Budesonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 24 USDMF, 28 CEP/COS, 7 JDMF, 7 EU WC, 15 KDMF, 36 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

72 Drugs in Development

72 Drugs in Development

INTERMEDIATES

7 Intermediates Suppliers

7 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

613 FDF Dossiers, 54 FDA Orange Book, 429 Europe, 23 Canada, 19 Australia, 35 South Africa, 53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 2 Seqens, 9 DKSH, 4 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

68 Coating Systems & Additives, 67 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 33 Thickeners and Stabilizers, 30 Direct Compression, 24 Solubilizers, 20 Film Formers & Plasticizers, 20 Granulation, 19 Lubricants & Glidants, 19 Taste Masking, 18 Topical, 15 Parenteral, 15 Co-Processed Excipients, 11 Disintegrants & Superdisintegrants, 9 Empty Capsules, 9 Emulsifying Agents, 6 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 129 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 232 Finished Drug Prices, 37 Annual Reports

MARKET PLACE

18 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

53 US Patents, 5 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 13 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls

Filters

Budesonide

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Evonik

filter Capability Reset all filters

filter Country Reset all filters

01

Evonik

Germany

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100-55

Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

EUDRAGIT® L 100-55

Excipients Web Link

Digital Content

02

Evonik

Germany

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® FS 30 D

Application : Solubilizers

Excipient Details : EUDRAGIT® FS 30 D (aqueous dispersion), a delayed release polymer, used to increase solubility of poorly soluble OSDs such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Excipient, Methyl Acrylate, Methyl Methacrylate

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Excipient, Methyl Acrylate, Methyl Methacrylate

Dosage Form : Capsule, Tablet

Category : Solubilizers

Brand : EUDRAGIT® FS 30 D

Applications : EUDRAGIT® FS 30 D (aqueous dispersion), a delayed release polymer, used to increase solubility of poorly soluble OSDs such as tablets and capsules.